Partner Content

How can pharma boost lung-cancer screening rates? Awareness is just the first step
How can pharma boost lung-cancer screening rates? Awareness is just the first step
Phreesia
May 23, 2022
4:57 pm

High-risk patients don’t know about screening options, survey shows — and many of those who do aren’t using them.

The truth about our relationships with health
The truth about our relationships with health
MM+M Staff
April 27, 2022
1:42 pm

MRM for Health’s new global study deconstructs our fraying relationship with health and healthcare.

4 ways commercial teams can address health equity
4 ways commercial teams can address health equity
Robyn Stoy, director, offering development, patient engagement, IQVIA
Timothy Barshinger, Ph.D., product and strategy director, patient support and adherence, IQVIA
April 25, 2022
11:00 am

The next frontier of innovation lies in thoughtfully utilizing patient support programs.

Pioneering lifechanging brands
Pioneering lifechanging brands
MM+M Staff
April 21, 2022
12:15 pm

A conversation with CDMP president Craig Romanok on keeping it fresh, fun and meaningful.

A decade of Healio
A decade of Healio
MM+M Staff
April 11, 2022
12:00 pm

In this podcast, Healio’s John C. Carter, chief operating officer and Joan-Marie Stiglich, ELS, chief content officer, discuss the origins and future of Healio.

Native advertising is exploding across healthcare, have you jumped in?
Native advertising is exploding across healthcare, have you jumped in?
Tap Native
March 29, 2022
11:44 am

In the last 2 years, and accelerated by COVID, native advertising has exploded across healthcare for DTC and HCP marketing.

Game Changers: GT Medical Technologies
Game Changers: GT Medical Technologies
GT Medical Technologies
March 28, 2022
4:10 pm

Our purpose is to improve the lives of patients with brain tumors. Our vision is to become the standard of care for operable brain tumors.

Why marketers must embrace privacy-safe real-world data
Why marketers must embrace privacy-safe real-world data
MM+M Staff
March 23, 2022
12:00 pm

A brand-exclusive approach to targeting patient audiences.

Fusion is ready to spark uncommon reactions
Fusion is ready to spark uncommon reactions
Lew Campanaro, general manager, Fusion
March 22, 2022
9:14 am

The agency provides essential support for state-of-the-art engagements, including scientific message platform development, opinion leader identification and more.

Fusion is ready to spark uncommon reactions
Fusion is ready to spark uncommon reactions
Fusion
March 10, 2022
5:00 am

The agency provides essential support for state-of-the-art engagements, including scientific message platform development, opinion leader identification and more.

  • From Our Partners